[Indications and pharmacokinetic study of lithium carbonate in the treatment of the acute phase of Basedow's disease].
D000328:Adult; D000368:Aged; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D007700:Kinetics; D008094:Lithium / Q000378:metabolism / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D008875:Middle Aged; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D016651:Lithium Carbonate; D002231:Carbimazole; D008094:Lithium; D013974:Thyroxine
Indication et étude pharmacocinétique du carbonate de lithium dans le traitement de la phase aiguë de la maladie de Basedow.